Leitlinie der Europäischen Gesellschaft für Gastrointestinale Endoskopie (ESGE) zum Einsatz von selbstexpandierenden Metallstents bei Obstruktionen durch Kolonkarzinome und extrakolische Karzinome
| Autor: | John M. DeWitt, George Webster, Jean-Marc Dumonceau, E. E. van Halsema, J. E. van Hooft, Michael C. Parker, Cesare Hassan, Pieter J. Tanis, Fergal Donnellan, Regina G. H. Beets-Tan, Rob Glynne-Jones, Charles Sabbagh, Søren Meisner, Javier Jiménez-Pérez, Jayesh Sagar, JM Regimbeau, A. Repici, Geoffroy Vanbiervliet, Jo G. Vandervoort, V. Raman Muthusamy, Marc Barthet, Gianpiero Manes |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
medicine.medical_specialty
Bevacizumab business.industry General surgery Standard treatment medicine.medical_treatment Gastroenterology Stent Guideline Colonic obstruction Colonic cancer medicine Radiology Nuclear Medicine and imaging Surgery Elective surgery business medicine.drug Gastrointestinal endoscopy |
| Zdroj: | Endoskopie heute. 27:246-255 |
| ISSN: | 1439-2577 0933-811X |
| DOI: | 10.1055/s-0034-1398787 |
| Popis: | This Guideline is an official statement of the European Society of Gastrointestinal Endoscopy (ESGE). This Guideline was also reviewed and endorsed by the Governing Board of the American Society for Gastrointestinal Endoscopy (ASGE). The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system was adopted to define the strength of recommendations and the quality of evidence. Main recommendations The following recommendations should only be applied after a thorough diagnostic evaluation including a contrast-enhanced computed tomography (CT) scan. Prophylactic colonic stent placement is not recommended. Colonic stenting should be reserved for patients with clinical symptoms and imaging evidence of malignant large-bowel obstruction, without signs of perforation (strong recommendation, low quality evidence). Colonic self-expandable metal stent (SEMS) placement as a bridge to elective surgery is not recommended as a standard treatment of symptomatic left-sided malignant colonic obstruction (strong recommendation, high quality evidence). For patients with potentially curable but obstructing left-sided colonic cancer, stent placement may be considered as an alternative to emergency surgery in those who have an increased risk of postoperative mortality, i.e. American Society of Anesthesiologists (ASA) Physical Status III and/or age >70 years (weak recommendation, low quality evidence). SEMS placement is recommended as the preferred treatment for palliation of malignant colonic obstruction (strong recommendation, high quality evidence), except in patients treated or considered for treatment with antiangiogenic drugs (e.g. bevacizumab) (strong recommendation, low quality evidence) |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|